Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.99.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.99.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.99.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.99.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.52EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.52ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.52ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.52EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.52EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.42ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.42EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.42EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.18.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.18.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.18.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.18.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.18.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LF.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LF.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LF.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LF.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LF.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDK.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDK.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used